Nil joined Polaris in 2022 and is a principal in the firm’s New York office. She is focused on biotech and healthcare investments.
Prior to joining Polaris, Nil was a manager at Bain & Company’s healthcare practice with a focus on pharma and medical devices. Before Bain, she was a part of the initial team at Glympse Bio where she helped develop their platform technology. She currently serves on the Board of Directors of August Bio, and as a Board Observer to EpiBiologics. She also works with other Polaris portfolio companies including Crossbow Therapeutics, FIRE1, and Satellite Bio.
Nil holds a PhD from the HST program of Harvard & MIT where she was an HHMI fellow and a BS in Biomedical Engineering from Washington University in St. Louis.